Effects of imipramine administration on μ-opioid receptor immunostaining in the rat forebrain

Arzneimittel-Forschung/Drug Research

Volumn 48, Issue 7, 1998, Pages 717-719

  De Gandarias, Juan Manuel ^a   Echevarria, Enrique ^a   Acebes, Iǹaky ^a   Silio, Margarita ^a   Casis, Luis ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Opioid receptors; Antidepressant; CAS 113 52 0; Imipramine, rat brain

Indexed keywords

IMIPRAMINE; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; FOREBRAIN; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; NONHUMAN; RAT; RECEPTOR DENSITY;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; IMIPRAMINE; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

EID: 0031876446     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Belluzi, J. D., Stein, L. L., Nature 266, 556 (1977)
2. Hiller, J. M., Zhang, Y., Bing, T. et al., Neuroscience 62, 829 (1994)
3. Kaneko, T., Minami, M., Satoh, M. et al., Neurosci. Lett. 84, 149 (1995)
4. Ding, Y. Q., Kneko, T., Normura, S. et al., J. Comp. Neurol. 367, 375 (1996)
5. Meana, J., García Sevilla, J., in: Fármacos antidepresivos PPU, Barcelona (1990)
6. Engleman, E. A., Wong, D. T., Chinese J. Physiol. 39, 9 (1996)
7. Maj, J., Dziedzicka-Wasylewska, M., Rogoz, R. et al., Eur. J. Pharmacol. 304, 49 (1996)
8. Ichikawa, J., Meltzer, H. Y., Eur. J. Pharmacol. 281, 255 (1995)
9. Humel, T., Humel, C., Friedel, Y. et al., Br. J. Clin. Pharmacol. 37, 325 (1994)
10. Tura, B., Tura, S., Brain Res. 518, 19 (1990)
11. De Felipe, M. C., De Caballos, M. L., Gil, C. et al., Eur. J. Pharmacol. 125, 193 (1986)
12. Eschalier, A., Montasture, J. L., Devoize, J. L. et al., Eur. J. Pharmacol. 76, 1 (1981)
13. Chaillet, P., Marcais-Collado, H., Costentin, J. et al., Eur. J. Pharmacol. 86, 329 (1983)
14. Gandarias, J. M. de, Casis, O., Varona, A. et al., Life Sci. 61, 321 (1997)
15. De Felipe, M. C., De Ceballos, M. L., Gil, C. et al., Eur. J. Pharmacol. 112, 119 (1985)
16. Kurumaji, A., Mitsushio, H., Takashima, M., Psychopharmacology 94, 188 (1988)
17. Micó, J. A., in: Fármacos antidepresivos, PPU, Barcelona (1990)
18. Valverde, O., Micó, J. A., Maldonado, R. et al., Prog. Neuropsychopharmacol. Biol. Psychiatry 18, 1073 (1994)
19. Gioannini, T. L., Yao, Y. H., Hiller, J. M. et al., Mol. Pharmacol. 44, 796 (1993)
20. Maneckjee, R., Archer, S., Zukin, R. S., J. Neuroimmunol. 17, 199 (1988)
21. Biegon, A., Samuel, D., Biochem. Pharmacol. 29, 460 (1980)
22. Somoza, E., Galindo, A., Bazán, E. et al., Neuropsychobiology 7, 297 (1981)
23. Isenberg, K. F., Cicero, T. J., Eur. J. Pharmacol. 103, 57 (1984)
24. Antkiewicz-Michalauk, L., Roscosz-Pelc, A., Vetulani, J., Eur. J. Pharmacol. 102, 179 (1984)
25. Baraldi, M., Poggioli, R., Santi, M. et al., Pharmacol. Res. Commun. 15, 843 (1983)
26. Stengaard-Pedersen, K., Scou, M., Neuropharmacology 25, 1365 (1986)
27. Reisine, T., Soubrie, P., Eur. J. Pharmacol. 77, 39 (1982)
28. Hamon, M., Gozlan, H., Bourgoin, S. et al., Neuropharmacology 26, 531 (1987)